Tilbage til menuen

2009

No	Author	Title	Media
1.	Allena M, Katsarava Z, Nappi G; COMOESTAS Consortium.	From drug-induced headache to medication overuse headache. A short epidemiological review, with a focus on Latin American countries.	J Headache Pain. 2009 Apr;10(2):71-6.
2.	Bendtsen L.	Drug and non-drug treatment in tension-type headache.	Therapeutic Advances in Neurological Disorders 2009;2(3):155-161.
3.	Bendtsen L, Jensen R.	Migraine and other headaches: Tension-type headache.	Neurologic Clinics, 2009;27:525-535.
4.	Bendtsen L, Bigal ME, Cerbo R, Diener HC, Holroyd K, Lampl C, Mitsikostas DD, Steiner TJ, Tfelt-Hansen P.	Guidelines for controlled trials of drugs in tension-type headache: second edition.	Cephalalgia 2009; Epub ahead of print.
5.	Buchgreitz, L.; Egsgaard, L.; Jensen, R.; Arendt-Nielsen, L.; Bendtsen, L.	Abnormal brain processing of pain in migraine without aura: a high-density EEG brain mapping study.	Cephalalgia 2009 Jul.
6.	Dahlof, C. G.; Hauge, A. W.; Olesen, J.	Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.	Cephalalgia 2009 Nov;29 Suppl 2:7-16.
7.	Daugaard, D.; Thomsen, L. L.; Iversen, H. K.; Olesen, J.	Delayed migraine-like headache in healthy volunteers after a combination of acetazolamide and glyceryl trinitrate.	Cephalalgia 2009 Dec;29(12):1294-1300.
8.	Ekbom, K.; Waldenlind, E.; Tfelt-Hansen, P.	Cluster headache and aura.	Headache 2009 May;49(5):786-787.
9.	Goadsby, P. J.; Ferrari, M. D.; Csanyi, A.; Olesen, J.; Mills, J. G.	Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.	Cephalalgia 2009 Jul;29(7):742-750.
10.	Gupta, S.; Bhatt, D. K.; Boni, L. J.; Olesen, J.	Improvement of the closed cranial window model in rats by intracarotid infusion of signalling molecules implicated in migraine.	Cephalalgia 2009 Apr.
11.	Hansen, J. M.; Petersen, J.; Wienecke, T.; Olsen, K. S.; Jensen, L. T.; Ashina, M.	Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteers.	J Headache Pain 2009 Apr;10(2):85-91.
12.	Hansen, J. S.; Bendtsen, L.; Jensen, R.	Psychometric properties of the Danish versions of headache-specific locus of control scale and headache management self-efficacy scale.	J Headache Pain 2009 Oct;10(5):341-347.
13.	Hauge, A.; Kirchmann, M.; Olesen, J.	Trigger factors in migraine with aura.	Cephalalgia 2009 Jul.
14.	Hauge, A. W.; Asghar, M. S.; Schytz, H. W.; Christensen, K.; Olesen, J.	Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study	Lancet Neurol 2009 Aug;8(8):718-723.
15.	Jensen, R.; Bendtsen, L.	Medication overuse headache in Scandinavia-comments and questions.	Cephalalgia 2009 Jul.
16.	Katsarava, Z.; Dzagnidze, A.; Kukava, M.; Mirvelashvili, E.; Djibuti, M.; Janelidze, M.; Jensen, R.; Stovner, L. J.; Steiner, T. J.	Prevalence of cluster headache in the Republic of Georgia: results of a population-based study and methodological considerations.	Cephalalgia 2009 Sep;29(9):949-952.
17.	Katsarava, Z.; Dzagnidze, A.; Kukava, M.; Mirvelashvili, E.; Djibuti, M.; Janelidze, M.; Jensen, R.; Stovner, L. J.; Steiner, T. J.	Primary headache disorders in the Republic of Georgia: prevalence and risk factors.	Neurology 2009 Nov;73(21):1796-1803.
18.	Katsarava Z, Dzagnidze A, Kukava M, Mirvelashvili E, Djibuti M, Janelidze M, Jensen R, Stovner LJ, Steiner TJ;	Global Campaign to Reduce the Burden of Headache Worldwide; Russian Linguistic Subcommittee of the International Headache Society.	Cephalalgia. 2009 Sep;29(9):949-52.
19.	Kruse, L. S.; Moller, M.; Tibaek, M.; Gammeltoft, S.; Olesen, J.; Kruuse, C.	PDE9A, PDE10A, and PDE11A expression in rat trigeminovascular pain signalling system.	Brain Res 2009 Jul;1281:25-34.
20.	Kruuse, C.; Iversen, H. K.; Jansen-Olesen, I.; Edvinsson, L.; Olesen, J.	Calcitonin gene-related peptide (CGRP) levels during glyceryl trinitrate (GTN)-induced headache in healthy volunteers.	Cephalalgia 2009 Aug.
21.	Lindelof, K.; Bendtsen, L.	Memantine for prophylaxis of chronic tension-type headache--a double-blind, randomized, crossover clinical trial.	Cephalalgia 2009 Mar;29(3):314-321.
22.	Lindelof, K.; Ellrich, J.; Jensen, R.; Bendtsen, L.	Central pain processing in chronic tension-type headache.	Clin Neurophysiol 2009 Jul;120(7):1364-1370.
23.	Lindelof, K.; Jung, K.; Ellrich, J.; Jensen, R.; Bendtsen, L.	Low-frequency electrical stimulation induces long-term depression in patients with cronic tension-type headache.	Cephalalgia 2010;[Epub ahead of print].
24.	Lindholt, M.; Petersen, K. A.; Tvedskov, J. F.; Iversen, H. K.; Olesen, J.; Tfelt-Hansen, P.	Lack of effect of norepinephrine on cranial haemodynamics and headache in healthy volunteers.	Cephalalgia 2009 Mar;29(3):384-387.
25.	Mensah A, Milea D, Jensen R, Fledelius H.	Persistent visual loss in Malignant Idiopathic Intracranial Hypertension.	Acta Opthamol. Scand 2009 87(8);934-6.
26.	Meyer, E. L.; Laurell, K.; Artto, V.; Bendtsen, L.; Linde, M.; Kallela, M.; Tronvik, E.; Zwart, J. A.; Jensen, R. M.; Hagen, K.	Lateralization in cluster headache: a Nordic multicenter study.	J Headache Pain 2009 Aug;10(4):259-263.
27.	Nielsen, T. H.; Tfelt-Hansen, P.; Iversen, H. K.	Assymetry of temporal artery diameters during spontaneous attacks of cluster headache.	Headache 2009 Mar;49(3):383-385.
28.	Olesen, J.	Dedicated chairs in headache science: the way forward?	Cephalalgia 2009 Jan;29(1):1-2.
29.	Olesen, J.	The future of headache classification and classification research.	Cephalalgia 2009 Dec;29(12):1240-1241.
30.	Olesen, J.; Burstein, R.; Ashina, M.; Tfelt-Hansen, P.	Origin of pain in migraine: evidence for peripheral sensitisation.	Lancet Neurol 2009 Jul;8(7):679-690.
31.	Olesen, J.; Steiner, T.; Bousser, M. G.; Diener, H. C.; Dodick, D.; First, M. B.; Goadsby, P. J.; Gobel, H.; Lainez, M. J.; Lipton, R. B.; Nappi, G.; Sakai, F.; Schoenen, J.; Silberstein, S. D.	Proposals for new standardized general diagnostic criteria for the secondary headaches.	Cephalalgia 2009 Dec;29(12):1331-1336.
32.	Olesen, J.; Tfelt-Hansen, P.; Ashina, M.	Finding new drug targets for the treatment of migraine attacks.	Cephalalgia 2009 Sep;29(9):909-920.
33.	Petersen, K. A.; Birk, S.; Kitamura, K.; Olesen, J.	Effect of adrenomedullin on the cerebral circulation: relevance to primary headache disorders.	Cephalalgia 2009 Jan;29(1):23-30.
34.	Poulsen, A. N.; Wulf, H.; Hay-Schmidt, A.; Jansen-Olesen, I.; Olesen, J.; Klaerke, D. A.	Differential expression of BK channel isoforms and beta-subunits in rat neuro-vascular tissues.	Biochim Biophys Acta 2009 Feb;1788(2):380-389.
35.	Rossi, P.; Jensen, R.; Nappi, G.; Allena, M.	A narrative review on the management of medication overuse headache: the steep road from experience to evidence.	J Headache Pain 2009 Dec;10(6):407-417.
36.	Schytz, H. W.; Birk, S.; Wienecke, T.; Kruuse, C.; Olesen, J.; Ashina, M.	PACAP38 induces migraine-like attacks in patients with migraine without aura.	Brain 2009 Jan;132(Pt 1):16-25.
37.	Schytz, H. W.; Ciftci, K.; Akin, A.; Ashina, M.; Bolay, H	Intact neurovascular coupling during executive function in migraine without aura: interictal near-infrared spectroscopy study.	Cephalalgia 2009 Aug.
38.	Schytz, H. W.; Wienecke, T.; Jensen, L. T.; Selb, J.; Boas, D. A.; Ashina, M.	Changes in cerebral blood flow after acetazolamide: an experimental study comparing near-infrared spectroscopy and SPECT.	Eur J Neurol 2009 Apr;16(4):461-467.
39.	Schytz, H. W.; Wienecke, T.; Olesen, J.; Ashina, M.	Carbachol induces headache, but not migraine-like attacks, in patients with migraine without aura.	Cephalalgia 2009 Jul.
40.	Schytz, H. W.; Wienecke, T.; Oturai, P. S.; Olesen, J.; Ashina, M.	The cholinomimetic agent carbachol induces headache in healthy subjects.	Cephalalgia 2009 Feb;29(2):258-268.
41.	Skau M, Jensen R, and Milea D.	[Rapidly progressing visual loss in idiopathic intracranial hypertension].	Ugeskr.Laeger. 171 (5):316-317, 2009.
42.	Tfelt-Hansen, P.	Migraine and telcagepant [corrected].	Lancet 2009 Mar;373(9668):1003-1004.
43.	Tfelt-Hansen, P.	What can be learned from the history of recurrence in migraine? A comment.	J Headache Pain 2009 Oct;10(5):311-315.
44.	Tfelt-Hansen, P.	[Triptans versus other migraine medicine--secondary publication].	Ugeskr Laeger 2009 Apr;171(18):1485-1487
45.	Tfelt-Hansen, P.; Ashina, M.	CGRP in migraine.	J Headache Pain 2009 Oct;10(5):385-388.
46.	Tfelt-Hansen, P.; Daugaard, D.; Lassen, L. H.; Iversen, H. K.; Olesen, J.	Prednisolone reduces nitric oxide-induced migraine.	Eur J Neurol 2009 Oct;16(10):1106-1111.
47.	Tfelt-Hansen, P.; Le, H.	Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review.	Headache Pain 2009 Jun;10(3):137-143.
48.	Tfelt-Hansen, P.; Olesen, J.	Posterior hypoperfusion in migraine without aura?	Cephalalgia 2009 Aug.
49.	Tfelt-Hansen, P.; Tfelt-Hansen, J.	Verapamil for cluster headache. Clinical pharmacology and possible mode of action.	Headache 2009 Jan;49(1):117-125.
50.	Tfelt-Hansen, P.	C. Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment.	J Headache Pain 2009 Dec;10(6):389-391.
51.	Tfelt-Hansen, P.	C. Unpublished clinical trials with sumatriptan.	Lancet 2009 Oct;374(9700):1501-1502.
52.	Tfelt-Hansen, P. C.; Tfelt-Hansen, J.	Nitroglycerin headache and nitroglycerin-induced primary headaches from 1846 and onwards: a historical overview and an update.	Headache 2009 Mar;49(3):445-456.
53.	Tibaek, S.; Gard, G.; Klarskov, P.; Iversen, H. K.; Dehlendorff, C.; Jensen, R.	Are activity limitations associated with lower urinary tract symptoms in stroke patients? A cross-sectional, clinical survey.	Scand J Urol Nephrol 2009 May;1-7.
54.	Tvedskov, J. F.; Iversen, H. K.; Olesen, J.; Tfelt-Hansen, P.	Nitroglycerin provocation in normal subjects is not a useful human migraine model?	Cephalalgia 2009 Sep.
55.	Villalon, C. M.; Olesen, J.	The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.	Pharmacol Ther 2009 Dec;124(3):309-323.
56.	Wienecke, T.; Olesen, J.; Ashina, M.	Prostaglandin I(2) (epoprostenol) triggers migraine-like attacks in migraineurs.	Cephalalgia 2009 Jul.
57.	Wienecke, T.; Olesen, J.; Oturai, P. S.; Ashina, M.	Prostaglandin E2(PGE2) induces headache in healthy subjects.	1. Cephalalgia 2009 May;29(5):509-519.
58.	Wulf, H.; Hay-Schmidt, A.; Poulsen, A. N.; Klaerke, D. A.; Olesen, J.; Jansen-Olesen, I.	Molecular investigations of BK(Ca) channels and the modulatory beta-subunits in porcine basilar and middle cerebral arteries.	J Mol Histol 2009 Apr;40(2):87-97.
59.	Wulf-Johansson, H.; Hay-Schmidt, A.; Poulsen, A. N.; Klaerke, D. A.; Olesen, J.; Jansen-Olesen, I.	Expression of BK Ca channels and the modulatory beta-subunits in the rat and porcine trigeminal ganglion.	Brain Res 2009 Oct;1292:1-13.
60.	Zeeberg, P.; Olesen, J.; Jensen, R.	Medication overuse headache and chronic migraine in a specialized headache centre: field-testing proposed new appendix criteria.	Cephalalgia 2009 Feb;29(2):214-220.

	PhD Thesis University of Copenhagen
1.	Lindelof K.	Antinociceptive mechanisms in chronic tension-type headache.	University of Copenhagen. Faculty of Health 2009: 1-49.
2.	Møller-Hansen J.	Familial hemiplegic migraine -an experimental genetic headache model.	Københavns Universitet. University of Copenhagen. Faculty of Health 2009: 1-127.
3.	Wienecke T.	Possible role of prostanoids in migraine and other headaches evaluated in an experimental human model.	University of Copenhagen. Faculty of Health 2009:1-47
	Book chapters in International Textbooks
1.	Jensen R.	Migræne og anden hovedpine	In: Smerter. Baggrund, Evidens og Behandling, edited by TS Jensen, JB Dahl, and L. Arendt-Nielsen, FADL, 2009, p. 209-218.

Redaktør

editor/Ditte Sjølund
E-mail: RVYcioap@3pm.regionh.dk

DHC

Danish Headache Center

Contact:

Danish Headache Center
DHC Glostrup Hospital Nord
Building 14
Ndr. Ringvej 69
DK-2600 Glostrup
Denmark

Phone: +45 38 63 20 62
Fax: +45 43 23 38 39

Location of Danish Headache Center - MAP